Trends in the prevalence of kidney stones in the United States from 2007 to 2016
The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with...
Saved in:
| Published in: | Urolithiasis Vol. 49; no. 1; pp. 27 - 39 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.02.2021
Springer Nature B.V |
| Subjects: | |
| ISSN: | 2194-7228, 2194-7236, 2194-7236 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007–2008 to 7.2% in 2011–2012 but then increased to 9.0% in 2013–2014 and 10.1% in 2015–2016. However, the overall prevalence of KS increased over 2007–2016 (
p
-trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20–79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20–59 years over 2007–2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011–2012 and increased to 10.6% in 2013–2014 and 12.1% in 2015–2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007–2008 and 7.4% in 2009–2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4–4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016. |
|---|---|
| AbstractList | The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007-2008 to 7.2% in 2011-2012 but then increased to 9.0% in 2013-2014 and 10.1% in 2015-2016. However, the overall prevalence of KS increased over 2007-2016 (p-trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20-79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20-59 years over 2007-2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011-2012 and increased to 10.6% in 2013-2014 and 12.1% in 2015-2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007-2008 and 7.4% in 2009-2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4-4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016. The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007-2008 to 7.2% in 2011-2012 but then increased to 9.0% in 2013-2014 and 10.1% in 2015-2016. However, the overall prevalence of KS increased over 2007-2016 (p-trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20-79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20-59 years over 2007-2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011-2012 and increased to 10.6% in 2013-2014 and 12.1% in 2015-2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007-2008 and 7.4% in 2009-2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4-4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016.The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007-2008 to 7.2% in 2011-2012 but then increased to 9.0% in 2013-2014 and 10.1% in 2015-2016. However, the overall prevalence of KS increased over 2007-2016 (p-trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20-79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20-59 years over 2007-2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011-2012 and increased to 10.6% in 2013-2014 and 12.1% in 2015-2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007-2008 and 7.4% in 2009-2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4-4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016. The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007–2008 to 7.2% in 2011–2012 but then increased to 9.0% in 2013–2014 and 10.1% in 2015–2016. However, the overall prevalence of KS increased over 2007–2016 (p-trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20–79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20–59 years over 2007–2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011–2012 and increased to 10.6% in 2013–2014 and 12.1% in 2015–2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007–2008 and 7.4% in 2009–2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4–4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016. The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007–2008 to 7.2% in 2011–2012 but then increased to 9.0% in 2013–2014 and 10.1% in 2015–2016. However, the overall prevalence of KS increased over 2007–2016 ( p -trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20–79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20–59 years over 2007–2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011–2012 and increased to 10.6% in 2013–2014 and 12.1% in 2015–2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007–2008 and 7.4% in 2009–2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4–4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016. |
| Author | Curhan, Gary Chewcharat, Api |
| Author_xml | – sequence: 1 givenname: Api orcidid: 0000-0002-1707-9988 surname: Chewcharat fullname: Chewcharat, Api email: api.che@hotmail.com organization: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Department of Medicine, Harvard Medical School, Mount Auburn Hospital – sequence: 2 givenname: Gary surname: Curhan fullname: Curhan, Gary organization: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Channing Laboratory and Renal Division, Department of Medicine, Brigham and Womens’ Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32870387$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtLAzEUhYNUbK39Ay4k4MbNaB4zk2QpxRcUFGzXYR6JTp0mNUkt_fem9iF00UC4IfnOzeGec9Ax1igALjG6xQixO48QSVGCSNyYYJQsT0CPYJEmjNC8sz8T3gUD76coLiFEitEZ6FLCGaKc9cDb2ClTe9gYGD4VnDv1U7TKVApaDb-a2qgV9CF-vUcmpgmqhu-hCPFSOzuDJBqCwcaK8wtwqovWq8G29sHk8WE8fE5Gr08vw_tRUlGWhUTTUuSMk5JlpWAl47zQGSZ5lZIapaIuM0EQL1NR6vjCiMYY6zyrmagpKZCgfXCz6Tt39nuhfJCzxleqbQuj7MJLklKRU0w5juj1ATq1C2eiu0jxnPMUZ2vqakstypmq5dw1s8Kt5G5WEeAboHLWe6e0rJo4hMaa4IqmlRjJdTJyk4yMyci_ZOQySsmBdNf9qIhuRD7C5kO5f9tHVL-D4Zwy |
| CitedBy_id | crossref_primary_10_1186_s41110_022_00165_9 crossref_primary_10_1007_s00240_023_01432_8 crossref_primary_10_1007_s11255_024_04111_8 crossref_primary_10_3390_diagnostics13040603 crossref_primary_10_34067_KID_0000000000000184 crossref_primary_10_3390_genes16050501 crossref_primary_10_3390_cryst13071070 crossref_primary_10_1016_j_euf_2021_08_004 crossref_primary_10_2147_PPA_S530289 crossref_primary_10_1007_s00345_024_05318_1 crossref_primary_10_1089_end_2022_0741 crossref_primary_10_1097_MOU_0000000000000994 crossref_primary_10_1016_j_abb_2023_109568 crossref_primary_10_1186_s12880_024_01228_1 crossref_primary_10_2217_cer_2022_0153 crossref_primary_10_1177_03915603251343168 crossref_primary_10_3389_fmed_2024_1432275 crossref_primary_10_1016_j_urology_2023_02_041 crossref_primary_10_1186_s12882_023_03421_w crossref_primary_10_1002_smll_202304941 crossref_primary_10_1016_j_csbj_2022_12_004 crossref_primary_10_1007_s10653_023_01515_w crossref_primary_10_1016_j_jep_2025_119846 crossref_primary_10_1016_j_tiv_2022_105320 crossref_primary_10_1038_s41585_021_00450_8 crossref_primary_10_3390_jcm14030997 crossref_primary_10_1016_j_eururo_2024_05_029 crossref_primary_10_1053_j_akdh_2024_08_007 crossref_primary_10_1080_07853890_2025_2519676 crossref_primary_10_1007_s00345_023_04463_3 crossref_primary_10_1097_MNH_0000000000000990 crossref_primary_10_1038_s41598_024_78061_7 crossref_primary_10_3389_fmed_2025_1558628 crossref_primary_10_1007_s00345_025_05492_w crossref_primary_10_1016_j_eclinm_2024_102924 crossref_primary_10_1038_s41443_024_00963_x crossref_primary_10_1007_s00261_023_04116_4 crossref_primary_10_7759_cureus_84981 crossref_primary_10_1093_ndt_gfae099 crossref_primary_10_1177_02841851251327892 crossref_primary_10_1016_j_biopha_2025_118003 crossref_primary_10_1002_ijgo_15858 crossref_primary_10_1007_s00018_022_04483_z crossref_primary_10_1016_j_ecoenv_2024_117189 crossref_primary_10_3389_fpubh_2023_1203640 crossref_primary_10_1159_000529094 crossref_primary_10_1186_s12882_024_03688_7 crossref_primary_10_3389_fphar_2025_1501386 crossref_primary_10_3390_medicina58101388 crossref_primary_10_1089_end_2022_0489 crossref_primary_10_1089_end_2022_0402 crossref_primary_10_2478_acss_2024_0014 crossref_primary_10_1080_1040841X_2022_2045899 crossref_primary_10_1016_j_mayocp_2023_12_009 crossref_primary_10_3390_jcm14051487 crossref_primary_10_1007_s11255_025_04453_x crossref_primary_10_1016_j_euros_2025_07_001 crossref_primary_10_1186_s12865_024_00627_x crossref_primary_10_3389_fnut_2023_1132597 crossref_primary_10_1089_end_2022_0086 crossref_primary_10_1186_s12894_024_01498_5 crossref_primary_10_1001_jamainternmed_2023_7660 crossref_primary_10_3390_jcm12123879 crossref_primary_10_1093_jbmrpl_ziae074 crossref_primary_10_3390_nu13061917 crossref_primary_10_1002_bco2_70038 crossref_primary_10_25259_Cytojournal_72_2024 crossref_primary_10_7759_cureus_57651 crossref_primary_10_1080_19490976_2025_2562337 crossref_primary_10_3390_jcm11061529 crossref_primary_10_1016_j_jad_2024_08_061 crossref_primary_10_1007_s00345_024_04919_0 crossref_primary_10_1089_end_2021_0048 crossref_primary_10_1007_s00240_024_01533_y crossref_primary_10_1007_s00345_023_04299_x crossref_primary_10_34067_KID_0000000882 crossref_primary_10_1038_s41598_025_95095_7 crossref_primary_10_1097_MNH_0000000000000856 crossref_primary_10_1007_s00240_023_01457_z crossref_primary_10_1007_s00345_022_04047_7 crossref_primary_10_1016_j_nutres_2024_06_006 crossref_primary_10_1093_rheumatology_keae262 crossref_primary_10_1016_j_semnephrol_2022_04_012 crossref_primary_10_3389_fendo_2023_1207943 crossref_primary_10_3389_fphys_2025_1612585 crossref_primary_10_1089_end_2022_0010 crossref_primary_10_3390_jpm12071120 crossref_primary_10_1186_s12894_025_01778_8 crossref_primary_10_1053_j_akdh_2024_09_001 crossref_primary_10_1371_journal_pone_0290389 crossref_primary_10_3389_fmed_2024_1501464 crossref_primary_10_3390_bioengineering9120811 crossref_primary_10_1002_ima_23022 crossref_primary_10_1186_s12864_023_09222_7 crossref_primary_10_1089_end_2021_0897 crossref_primary_10_1155_2021_5361415 crossref_primary_10_1007_s00240_025_01788_z crossref_primary_10_1136_bmj_2024_080035 crossref_primary_10_1016_j_urology_2023_03_040 crossref_primary_10_1097_MOU_0000000000001002 crossref_primary_10_3390_healthcare11030424 crossref_primary_10_3390_nu13124434 crossref_primary_10_1016_S1761_3310_25_50732_6 crossref_primary_10_33719_nju1560480 crossref_primary_10_1186_s12894_024_01414_x crossref_primary_10_5802_crchim_185 crossref_primary_10_1007_s00240_025_01843_9 crossref_primary_10_1136_bmjopen_2024_096533 crossref_primary_10_1007_s00120_025_02617_2 crossref_primary_10_1016_j_heliyon_2024_e33155 crossref_primary_10_3389_fendo_2022_1032323 crossref_primary_10_1038_s41598_024_80147_1 crossref_primary_10_1148_radiol_232453 crossref_primary_10_1007_s00394_024_03553_1 crossref_primary_10_3390_ijms241310879 crossref_primary_10_2215_CJN_0000000000000428 crossref_primary_10_1056_NEJMoa2209275 crossref_primary_10_2174_0113894501346592250505050431 crossref_primary_10_1016_j_micres_2024_127663 crossref_primary_10_3390_cryst14100854 crossref_primary_10_1055_a_2038_0931 crossref_primary_10_3390_clinpract14030072 crossref_primary_10_3389_fphar_2025_1511115 crossref_primary_10_3390_bioengineering10080970 crossref_primary_10_1016_j_mayocp_2022_04_016 crossref_primary_10_1007_s00345_022_04060_w crossref_primary_10_1089_end_2022_0557 crossref_primary_10_3389_fnut_2025_1549047 crossref_primary_10_1007_s00240_020_01219_1 crossref_primary_10_3390_pathogens14070670 crossref_primary_10_1007_s11255_024_04084_8 crossref_primary_10_1186_s12889_024_18307_1 crossref_primary_10_2478_bgbl_2024_0006 crossref_primary_10_14777_uti_2448018009 crossref_primary_10_1007_s11255_025_04784_9 crossref_primary_10_1016_j_phymed_2023_155196 crossref_primary_10_1136_bmjopen_2025_101594 crossref_primary_10_1007_s00345_023_04360_9 crossref_primary_10_1186_s12889_023_17128_y crossref_primary_10_4103_njcp_njcp_311_24 crossref_primary_10_1097_MD_0000000000044653 crossref_primary_10_1007_s11255_025_04644_6 crossref_primary_10_1016_j_micpath_2025_107641 crossref_primary_10_3390_jcm13237191 crossref_primary_10_1016_j_urology_2025_02_021 crossref_primary_10_1097_MD_0000000000037050 crossref_primary_10_1007_s00240_024_01617_9 crossref_primary_10_1186_s12894_022_01017_4 crossref_primary_10_1016_j_jep_2024_118950 crossref_primary_10_1016_j_microc_2025_115047 crossref_primary_10_3390_nu16060783 crossref_primary_10_1016_j_advnut_2023_03_002 crossref_primary_10_1210_jcemcr_luaf077 crossref_primary_10_1007_s00240_023_01423_9 crossref_primary_10_1007_s00240_022_01403_5 crossref_primary_10_3389_fendo_2024_1289553 crossref_primary_10_3389_fnut_2024_1463352 crossref_primary_10_3390_medicina59030475 crossref_primary_10_3390_jcm10050978 crossref_primary_10_3389_fnut_2023_1226082 crossref_primary_10_1097_MNH_0000000000000892 crossref_primary_10_1038_s41591_024_03330_x crossref_primary_10_1089_end_2022_0458 crossref_primary_10_1007_s00240_024_01668_y crossref_primary_10_1093_ndt_gfae074 crossref_primary_10_1097_MOU_0000000000001271 crossref_primary_10_1007_s11914_024_00888_w crossref_primary_10_1016_j_euros_2025_01_003 crossref_primary_10_1093_ckj_sfad034 |
| Cites_doi | 10.15585/mmwr.mm6542a3 10.4103/UROS.UROS_20_17 10.2215/cjn.04960513 10.1136/bmj.e5287 10.4103/1947-2714.145477 10.1016/S0022-5347(05)65925-3 10.4081/aiua.2015.1.83 10.1210/jc.2011-0385 10.1007/BF02549826 10.2215/CJN.07190712 10.1016/j.juro.2017.02.3233 10.2215/CJN.10651110 10.1681/ASN.2007020219 10.1007/s00240-018-1050-1 10.2215/CJN.07610715 10.1016/j.mayocp.2016.08.014 10.1007/s00240-016-0888-3 10.1016/S0022-5347(17)40997-9 10.4103/2230-8210.94248 10.1001/jama.2015.4260 10.1016/j.eururo.2012.03.052 10.1111/j.1523-1755.2005.00516.x 10.1046/j.1523-1755.2001.00746.x 10.3978/j.issn.2223-4683.2014.07.02 10.1177/2051415818813820 10.1016/j.mayocp.2017.11.018 10.1053/j.ajkd.2012.12.028 10.3390/nu10030366 10.1002/art.40807 10.1038/sj.ki.5002708 10.1007/s00240-016-0954-x 10.1007/978-1-4471-4387-1_14 10.1016/j.juro.2018.01.077 10.1001/jama.293.4.455 10.1089/pop.2015.0181 10.2215/CJN.03210312 10.1210/jc.2009-1796 10.1038/nrendo.2010.206 10.1007/s00240-019-01151-z 10.1161/HYPERTENSIONAHA.114.04012 10.1097/01.ju.0000033907.21910.be 10.1371/journal.pone.0075513 10.1016/S0094-0143(05)70257-3 10.1155/2018/3068365 10.1001/jama.2018.3060 10.2215/cjn.07060714 10.1002/oby.22370 10.1016/j.juro.2016.08.084 10.1016/j.juro.2015.12.069 10.1681/asn.2006080854 10.1038/sj.ki.5001656 10.1046/j.1523-1755.2003.00917.x 10.1046/j.1523-1755.2003.00725.x 10.2337/dc10-2339 10.1016/j.eururo.2014.06.036 |
| ContentType | Journal Article |
| Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2020 Springer-Verlag GmbH Germany, part of Springer Nature 2020. |
| Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2020 – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2020. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00240-020-01210-w |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2194-7236 |
| EndPage | 39 |
| ExternalDocumentID | 32870387 10_1007_s00240_020_01210_w |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GroupedDBID | -EM .VR 06C 06D 0R~ 203 29~ 2J2 2JN 2JY 2KG 2KM 2LR 3V. 4.4 406 408 40E 53G 5C9 5VS 7X7 88E 8FI 8FJ 8UJ 95- 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACPIV ACUDM ACZOJ ADBBV ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGWZB AGYKE AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BDATZ BGNMA BSONS BVXVI CCPQU CSCUP DDRTE DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN ESBYG FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ8 GRRUI H13 HF~ HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IKXTQ IMOTQ IWAJR IXD IZIGR I~Z J-C J0Z JBSCW JCJTX JZLTJ KOV LLZTM M1P M4Y MA- N2Q NPVJJ NQJWS NU0 O93 O9G O9J PF0 PQQKQ PROAC PSQYO PT4 QOR R89 RIG ROL RSV S16 SAP SCLPG SDE SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN TSG TUC U9L UG4 UKHRP UOJIU UTJUX UZXMN VFIZW W23 W48 YLTOR ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY ABUWG BENPR CGR CUY CVF ECM EIF NPM 7XB 8AO 8FK FYUFA K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c375t-f3b96782b75b97b788af5126c42d049db59208b49bf8af72f111f65d79d32a093 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 196 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000565121400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2194-7228 2194-7236 |
| IngestDate | Wed Oct 01 14:54:19 EDT 2025 Tue Nov 04 23:00:44 EST 2025 Mon Jul 21 06:05:25 EDT 2025 Tue Nov 18 22:51:24 EST 2025 Sat Nov 29 05:55:24 EST 2025 Fri Feb 21 02:48:50 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | NHANES Prevalence Nephrolithiasis Trends Kidney stone |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c375t-f3b96782b75b97b788af5126c42d049db59208b49bf8af72f111f65d79d32a093 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-1707-9988 |
| PMID | 32870387 |
| PQID | 2486884151 |
| PQPubID | 326290 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_2439631381 proquest_journals_2486884151 pubmed_primary_32870387 crossref_citationtrail_10_1007_s00240_020_01210_w crossref_primary_10_1007_s00240_020_01210_w springer_journals_10_1007_s00240_020_01210_w |
| PublicationCentury | 2000 |
| PublicationDate | 20210200 2021-02-00 2021-Feb 20210201 |
| PublicationDateYYYYMMDD | 2021-02-01 |
| PublicationDate_xml | – month: 2 year: 2021 text: 20210200 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Urolithiasis |
| PublicationTitleAbbrev | Urolithiasis |
| PublicationTitleAlternate | Urolithiasis |
| PublicationYear | 2021 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Rowley, Bezold, Arikan, Byrne, Krohe (CR34) 2017; 20 Curhan, Willett, Speizer, Stampfer (CR30) 2001; 59 Haley, Enders, Vaughan, Mehta, Thoman, Vrtiska, Krambeck, Lieske, Rule (CR48) 2016; 91 El-Zoghby, Lieske, Foley, Bergstralh, Li, Melton, Krambeck, Rule (CR5) 2012; 7 Wilson (CR47) 2011; 7 Taylor, Curhan (CR50) 2006; 70 Buckalew (CR25) 1989; 141 Stamatelou, Francis, Jones, Nyberg, Curhan (CR15) 2003; 63 Romero, Akpinar, Assimos (CR12) 2010; 12 Letavernier, Daudon (CR57) 2018; 10 Taylor, Stampfer, Curhan (CR29) 2005; 293 Alexander, Hemmelgarn, Wiebe, Bello, Morgan, Samuel, Klarenbach, Curhan, Tonelli (CR4) 2012; 345 Chen, Prosperi, Bird (CR10) 2018 Alelign, Petros (CR11) 2018; 2018 Meyer, Angino (CR52) 1977; 14 Ferraro, Gambaro, Curhan, Taylor (CR53) 2018; 199 Hyams, Matlaga (CR1) 2014; 3 Talati, Soares, Khambati, Nadler, Perry (CR60) 2020; 48 Rule, Krambeck, Lieske (CR2) 2011; 6 Heller, Sakhaee, Moe, Pak (CR45) 2002; 168 Zhao, Mai, Ou, Duan, Zeng (CR46) 2013; 8 Polat, Ozcan, Otunctemur, Ozbek (CR40) 2016; 44 Lu, Chien, Li, Chou, Wu, Huang (CR7) 2018; 29 Salam, Kshetrimayum, Keisam (CR43) 2012; 16 Fan, Chandhoke, Grampsas (CR38) 1999; 10 Johri, Jaeger, Ferraro, Shavit, Nair, Robertson, Gambaro, Unwin (CR54) 2017; 45 Wang, Jackson, Jones, Matsumoto, Nehra, Perelman, Swerdloff, Traish, Zitzmann, Cunningham (CR41) 2011; 34 Talati, Haroon, Trinchieri, Talati, Tiselius, Albala, Ye (CR24) 2012 Cheungpasitporn, Thongprayoon, Mao, O’Corragain, Edmonds, Erickson (CR9) 2014; 6 Taylor, Curhan (CR31) 2007; 18 Tajar, Forti, O’Neill, Lee, Silman, Finn, Bartfai, Boonen, Casanueva, Giwercman, Han, Kula, Labrie, Lean, Pendleton, Punab, Vanderschueren, Huhtaniemi, Wu (CR42) 2010; 95 Taylor, Stampfer, Curhan (CR28) 2005; 68 Komleh, Hada, Pendse, Singh (CR51) 1990; 22 Scales, Smith, Hanley, Saigal (CR17) 2012; 62 Hales, Fryar, Carroll, Freedman, Ogden (CR19) 2018; 319 Taylor, Feskanich, Paik, Curhan (CR6) 2016; 195 Chen-Xu, Yokose, Rai, Pillinger, Choi (CR21) 2019; 71 CR13 Kohjimoto, Sasaki, Iguchi, Matsumura, Inagaki, Hara (CR44) 2013; 61 Ferraro, Taylor, Gambaro, Curhan (CR55) 2017; 197 Taylor, Curhan (CR23) 2007; 18 Antonelli, Maalouf, Pearle, Lotan (CR16) 2014; 66 Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley, Heaney, Murad, Weaver (CR14) 2011; 96 Reinstatler, Khaleel, Pais (CR22) 2017; 198 Otunctemur, Ozbek, Cakir, Dursun, Polat, Ozcan, Besiroglu (CR39) 2015; 87 Curhan, Taylor (CR49) 2008; 73 Palmer, Toth (CR20) 2019; 27 Mandel, Taylor, Curhan (CR32) 2013; 8 Yagisawa, Ito, Osaka, Amano, Kobayashi, Toma (CR36) 2001; 166 Kittanamongkolchai, Vaughan, Enders, Dhondup, Mehta, Krambeck, McCollough, Vrtiska, Lieske, Rule (CR59) 2018; 93 Rodman, Mahler (CR27) 2000; 27 Parks, Worcester, O’Connor, Coe (CR26) 2003; 63 Tasian, Ross, Song, Sas, Keren, Denburg, Chu, Copelovitch, Saigal, Furth (CR58) 2016; 11 Alexander, Hemmelgarn, Wiebe, Bello, Samuel, Klarenbach, Curhan, Tonelli (CR8) 2014; 9 Aguilar, Bhuket, Torres, Liu, Wong (CR35) 2015; 313 Taylor, Hoofnagle, Curhan (CR56) 2015; 10 Yoon Sung, Gu, Nwankwo, Wright Jacqueline, Hong, Burt (CR18) 2015; 65 Dahlhamer, Zammitti, Ward, Wheaton, Croft (CR33) 2016; 65 Soundararajan, Mahesh, Ramesh, Begum (CR37) 2006; 44 Li, Chien, Wu, Huang, Chou (CR3) 2018; 46 MF Holick (1210_CR14) 2011; 96 C Wilson (1210_CR47) 2011; 7 PM Ferraro (1210_CR55) 2017; 197 VM Talati (1210_CR60) 2020; 48 W Cheungpasitporn (1210_CR9) 2014; 6 S Yoon Sung (1210_CR18) 2015; 65 M Aguilar (1210_CR35) 2015; 313 CD Scales Jr (1210_CR17) 2012; 62 K Komleh (1210_CR51) 1990; 22 EC Polat (1210_CR40) 2016; 44 EN Taylor (1210_CR6) 2016; 195 A Tajar (1210_CR42) 2010; 95 JJ Talati (1210_CR24) 2012 ES Hyams (1210_CR1) 2014; 3 RT Alexander (1210_CR4) 2012; 345 JA Antonelli (1210_CR16) 2014; 66 EN Taylor (1210_CR23) 2007; 18 HJ Heller (1210_CR45) 2002; 168 ZM El-Zoghby (1210_CR5) 2012; 7 L Reinstatler (1210_CR22) 2017; 198 JM Dahlhamer (1210_CR33) 2016; 65 JL Meyer (1210_CR52) 1977; 14 GC Curhan (1210_CR30) 2001; 59 T Alelign (1210_CR11) 2018; 2018 EN Taylor (1210_CR50) 2006; 70 C Wang (1210_CR41) 2011; 34 AD Rule (1210_CR2) 2011; 6 JH Parks (1210_CR26) 2003; 63 WE Haley (1210_CR48) 2016; 91 A Otunctemur (1210_CR39) 2015; 87 Z Chen (1210_CR10) 2018 EN Taylor (1210_CR56) 2015; 10 J Fan (1210_CR38) 1999; 10 EN Taylor (1210_CR29) 2005; 293 T Yagisawa (1210_CR36) 2001; 166 RT Alexander (1210_CR8) 2014; 9 E Letavernier (1210_CR57) 2018; 10 CM Hales (1210_CR19) 2018; 319 GC Curhan (1210_CR49) 2008; 73 JS Rodman (1210_CR27) 2000; 27 C-C Li (1210_CR3) 2018; 46 YM Lu (1210_CR7) 2018; 29 1210_CR13 P Soundararajan (1210_CR37) 2006; 44 WR Rowley (1210_CR34) 2017; 20 Y Kohjimoto (1210_CR44) 2013; 61 M Chen-Xu (1210_CR21) 2019; 71 VM Buckalew Jr (1210_CR25) 1989; 141 R Salam (1210_CR43) 2012; 16 Z Zhao (1210_CR46) 2013; 8 GE Tasian (1210_CR58) 2016; 11 MK Palmer (1210_CR20) 2019; 27 EN Taylor (1210_CR31) 2007; 18 EI Mandel (1210_CR32) 2013; 8 N Johri (1210_CR54) 2017; 45 KK Stamatelou (1210_CR15) 2003; 63 W Kittanamongkolchai (1210_CR59) 2018; 93 EN Taylor (1210_CR28) 2005; 68 PM Ferraro (1210_CR53) 2018; 199 V Romero (1210_CR12) 2010; 12 37965514 - Front Public Health. 2023 Oct 27;11:1203640 34111940 - J Urol. 2021 Sep;206(3):765-767 |
| References_xml | – volume: 65 start-page: 1166 year: 2016 end-page: 1169 ident: CR33 article-title: Prevalence of inflammatory bowel disease among adults aged ≥ 18 years — United States publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6542a3 – volume: 29 start-page: 145 issue: 3 year: 2018 end-page: 150 ident: CR7 article-title: Urolithiasis is associated with the increased risk for osteoporosis: a nationwide 9-year follow-up study publication-title: Urol Sci doi: 10.4103/UROS.UROS_20_17 – volume: 9 start-page: 506 issue: 3 year: 2014 end-page: 512 ident: CR8 article-title: Kidney stones and cardiovascular events: a cohort study publication-title: Clin J Am Soc Nephrol doi: 10.2215/cjn.04960513 – volume: 345 start-page: e5287 year: 2012 ident: CR4 article-title: Kidney stones and kidney function loss: a cohort study publication-title: BMJ (Clin Res Ed) doi: 10.1136/bmj.e5287 – volume: 6 start-page: 580 issue: 11 year: 2014 end-page: 585 ident: CR9 article-title: The risk of coronary heart disease in patients with kidney stones: a systematic review and meta-analysis publication-title: N Am J Med Sci doi: 10.4103/1947-2714.145477 – volume: 166 start-page: 1078 issue: 3 year: 2001 end-page: 1082 ident: CR36 article-title: The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis publication-title: J Urol doi: 10.1016/S0022-5347(05)65925-3 – volume: 87 start-page: 83 issue: 1 year: 2015 end-page: 86 ident: CR39 article-title: Urolithiasis is associated with low serum testosterone levels in men publication-title: Arch Ital Urol Androl doi: 10.4081/aiua.2015.1.83 – volume: 96 start-page: 1911 issue: 7 year: 2011 end-page: 1930 ident: CR14 article-title: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-0385 – volume: 22 start-page: 113 issue: 2 year: 1990 end-page: 118 ident: CR51 article-title: Zine, copper and manganese in serum, urine and stones publication-title: Int Urol Nephrol doi: 10.1007/BF02549826 – volume: 12 start-page: e86 issue: 2–3 year: 2010 end-page: e96 ident: CR12 article-title: Kidney stones: a global picture of prevalence, incidence, and associated risk factors publication-title: Rev Urol – volume: 8 start-page: 901 issue: 6 year: 2013 ident: CR32 article-title: Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.07190712 – volume: 198 start-page: 389 issue: 2 year: 2017 end-page: 393 ident: CR22 article-title: Association of pregnancy with stone formation among women in the United States: a NHANES Analysis 2007 to 2012 publication-title: J Urol doi: 10.1016/j.juro.2017.02.3233 – volume: 6 start-page: 2069 issue: 8 year: 2011 end-page: 2075 ident: CR2 article-title: Chronic kidney disease in kidney stone formers publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.10651110 – volume: 18 start-page: 2198 issue: 7 year: 2007 ident: CR31 article-title: Oxalate Intake and the risk for nephrolithiasis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007020219 – volume: 10 start-page: S376 issue: Suppl 14 year: 1999 end-page: S380 ident: CR38 article-title: Role of sex hormones in experimental calcium oxalate nephrolithiasis publication-title: J Am Soc Nephrol – volume: 46 start-page: 543 issue: 6 year: 2018 end-page: 547 ident: CR3 article-title: Uric acid stones increase the risk of chronic kidney disease publication-title: Urolithiasis doi: 10.1007/s00240-018-1050-1 – volume: 11 start-page: 488 issue: 3 year: 2016 ident: CR58 article-title: Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.07610715 – volume: 91 start-page: 1744 issue: 12 year: 2016 end-page: 1752 ident: CR48 article-title: Kidney function after the first kidney stone event publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2016.08.014 – volume: 44 start-page: 409 issue: 5 year: 2016 end-page: 413 ident: CR40 article-title: Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels publication-title: Urolithiasis doi: 10.1007/s00240-016-0888-3 – volume: 141 start-page: 731 issue: 3 Pt 2 year: 1989 end-page: 737 ident: CR25 article-title: Nephrolithiasis in renal tubular acidosis publication-title: J Urol doi: 10.1016/S0022-5347(17)40997-9 – volume: 16 start-page: S12 year: 2012 end-page: S19 ident: CR43 article-title: Testosterone and metabolic syndrome: The link publication-title: Indian J Endocrinol Metab doi: 10.4103/2230-8210.94248 – volume: 313 start-page: 1973 issue: 19 year: 2015 end-page: 1974 ident: CR35 article-title: Prevalence of the metabolic syndrome in the United States, 2003-2012 publication-title: JAMA doi: 10.1001/jama.2015.4260 – volume: 62 start-page: 160 issue: 1 year: 2012 end-page: 165 ident: CR17 article-title: Prevalence of kidney stones in the United States publication-title: Eur Urol doi: 10.1016/j.eururo.2012.03.052 – volume: 68 start-page: 1230 issue: 3 year: 2005 end-page: 1235 ident: CR28 article-title: Diabetes mellitus and the risk of nephrolithiasis publication-title: Kidney Int doi: 10.1111/j.1523-1755.2005.00516.x – volume: 59 start-page: 2290 issue: 6 year: 2001 end-page: 2298 ident: CR30 article-title: Twenty-four-hour urine chemistries and the risk of kidney stones among women and men publication-title: Kidney Int doi: 10.1046/j.1523-1755.2001.00746.x – volume: 3 start-page: 278 issue: 3 year: 2014 end-page: 283 ident: CR1 article-title: Economic impact of urinary stones publication-title: Transl Androl Urol doi: 10.3978/j.issn.2223-4683.2014.07.02 – year: 2018 ident: CR10 article-title: Prevalence of kidney stones in the USA: the national health and nutrition evaluation survey publication-title: J Clin Urol doi: 10.1177/2051415818813820 – volume: 93 start-page: 291 issue: 3 year: 2018 end-page: 299 ident: CR59 article-title: The changing incidence and presentation of urinary stones over 3 decades publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2017.11.018 – volume: 61 start-page: 923 issue: 6 year: 2013 end-page: 929 ident: CR44 article-title: Association of metabolic syndrome traits and severity of kidney stones: results from a Nationwide Survey on urolithiasis in Japan publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2012.12.028 – volume: 10 start-page: 366 issue: 3 year: 2018 ident: CR57 article-title: Vitamin D, hypercalciuria and kidney stones publication-title: Nutrients doi: 10.3390/nu10030366 – volume: 71 start-page: 991 issue: 6 year: 2019 end-page: 999 ident: CR21 article-title: Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016 publication-title: Arthr Rheumatol doi: 10.1002/art.40807 – volume: 73 start-page: 489 issue: 4 year: 2008 end-page: 496 ident: CR49 article-title: 24-h uric acid excretion and the risk of kidney stones publication-title: Kidney Int doi: 10.1038/sj.ki.5002708 – volume: 45 start-page: 535 issue: 6 year: 2017 end-page: 543 ident: CR54 article-title: Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? publication-title: Urolithiasis doi: 10.1007/s00240-016-0954-x – start-page: 107 year: 2012 end-page: 110 ident: CR24 article-title: Renal stone disease in different racial groups publication-title: Urolithiasis: basic science and clinical practice doi: 10.1007/978-1-4471-4387-1_14 – volume: 199 start-page: 1534 issue: 6 year: 2018 end-page: 1539 ident: CR53 article-title: Intake of trace metals and the risk of incident kidney stones publication-title: J Urol doi: 10.1016/j.juro.2018.01.077 – volume: 293 start-page: 455 issue: 4 year: 2005 end-page: 462 ident: CR29 article-title: Obesity, weight gain, and the risk of kidney stones publication-title: JAMA doi: 10.1001/jama.293.4.455 – volume: 20 start-page: 6 issue: 1 year: 2017 end-page: 12 ident: CR34 article-title: Diabetes 2030: insights from yesterday, today, and future trends publication-title: Popul Health Manag doi: 10.1089/pop.2015.0181 – volume: 7 start-page: 1409 issue: 9 year: 2012 end-page: 1415 ident: CR5 article-title: Urolithiasis and the risk of ESRD publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03210312 – volume: 95 start-page: 1810 issue: 4 year: 2010 end-page: 1818 ident: CR42 article-title: Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-1796 – volume: 7 start-page: 3 issue: 1 year: 2011 ident: CR47 article-title: Estrogen and kidney stones publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2010.206 – volume: 48 start-page: 305 issue: 4 year: 2020 end-page: 311 ident: CR60 article-title: Trends in urinary calculi composition from 2005 to 2015: a single tertiary center study publication-title: Urolithiasis doi: 10.1007/s00240-019-01151-z – volume: 65 start-page: 54 issue: 1 year: 2015 end-page: 61 ident: CR18 article-title: Trends in blood pressure among adults with hypertension publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.04012 – volume: 168 start-page: 1923 issue: 5 year: 2002 end-page: 1927 ident: CR45 article-title: Etiological role of estrogen status in renal stone formation publication-title: J Urol doi: 10.1097/01.ju.0000033907.21910.be – volume: 8 start-page: e75513 issue: 9 year: 2013 ident: CR46 article-title: Serum estradiol and testosterone levels in kidney stones disease with and without calcium oxalate components in naturally postmenopausal women publication-title: PLoS ONE doi: 10.1371/journal.pone.0075513 – volume: 27 start-page: 275 issue: 2 year: 2000 end-page: 285 ident: CR27 article-title: Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis publication-title: Urol Clin North Am doi: 10.1016/S0094-0143(05)70257-3 – volume: 2018 start-page: 3068365 year: 2018 ident: CR11 article-title: Kidney stone disease: an update on current concepts publication-title: Adv Urol doi: 10.1155/2018/3068365 – volume: 319 start-page: 1723 issue: 16 year: 2018 end-page: 1725 ident: CR19 article-title: Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016 publication-title: JAMA doi: 10.1001/jama.2018.3060 – volume: 10 start-page: 667 issue: 4 year: 2015 end-page: 675 ident: CR56 article-title: Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones publication-title: Clin J Am Soc Nephrol doi: 10.2215/cjn.07060714 – volume: 27 start-page: 309 issue: 2 year: 2019 end-page: 314 ident: CR20 article-title: Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: an NHANES analysis (2003-2004 to 2013-2014) publication-title: Obesity doi: 10.1002/oby.22370 – volume: 197 start-page: 405 issue: 2 year: 2017 end-page: 410 ident: CR55 article-title: Vitamin D intake and the risk of incident kidney stones publication-title: J Urol doi: 10.1016/j.juro.2016.08.084 – volume: 44 start-page: 981 issue: 12 year: 2006 end-page: 986 ident: CR37 article-title: Effect of Aerva lanata on calcium oxalate urolithiasis in rats publication-title: Indian J Exp Biol – volume: 195 start-page: 1482 issue: 5 year: 2016 end-page: 1486 ident: CR6 article-title: Nephrolithiasis and risk of incident bone fracture publication-title: J Urol doi: 10.1016/j.juro.2015.12.069 – volume: 18 start-page: 654 issue: 2 year: 2007 end-page: 659 ident: CR23 article-title: Differences in 24-Hour urine composition between black and white women publication-title: J Am Soc Nephrol doi: 10.1681/asn.2006080854 – ident: CR13 – volume: 70 start-page: 835 issue: 5 year: 2006 end-page: 839 ident: CR50 article-title: Diet and fluid prescription in stone disease publication-title: Kidney Int doi: 10.1038/sj.ki.5001656 – volume: 14 start-page: 347 issue: 5 year: 1977 end-page: 350 ident: CR52 article-title: The role of trace metals in calcium urolithiasis publication-title: Invest Urol – volume: 63 start-page: 1817 issue: 5 year: 2003 end-page: 1823 ident: CR15 article-title: Time trends in reported prevalence of kidney stones in the United States: 1976–1994 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00917.x – volume: 63 start-page: 255 issue: 1 year: 2003 end-page: 265 ident: CR26 article-title: Urine stone risk factors in nephrolithiasis patients with and without bowel disease publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00725.x – volume: 34 start-page: 1669 issue: 7 year: 2011 end-page: 1675 ident: CR41 article-title: Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc10-2339 – volume: 66 start-page: 724 issue: 4 year: 2014 end-page: 729 ident: CR16 article-title: Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030 publication-title: Eur Urol doi: 10.1016/j.eururo.2014.06.036 – volume: 73 start-page: 489 issue: 4 year: 2008 ident: 1210_CR49 publication-title: Kidney Int doi: 10.1038/sj.ki.5002708 – volume: 195 start-page: 1482 issue: 5 year: 2016 ident: 1210_CR6 publication-title: J Urol doi: 10.1016/j.juro.2015.12.069 – volume: 70 start-page: 835 issue: 5 year: 2006 ident: 1210_CR50 publication-title: Kidney Int doi: 10.1038/sj.ki.5001656 – volume: 11 start-page: 488 issue: 3 year: 2016 ident: 1210_CR58 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.07610715 – volume: 345 start-page: e5287 year: 2012 ident: 1210_CR4 publication-title: BMJ (Clin Res Ed) doi: 10.1136/bmj.e5287 – volume: 198 start-page: 389 issue: 2 year: 2017 ident: 1210_CR22 publication-title: J Urol doi: 10.1016/j.juro.2017.02.3233 – volume: 10 start-page: 366 issue: 3 year: 2018 ident: 1210_CR57 publication-title: Nutrients doi: 10.3390/nu10030366 – volume: 65 start-page: 54 issue: 1 year: 2015 ident: 1210_CR18 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.04012 – volume: 65 start-page: 1166 year: 2016 ident: 1210_CR33 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6542a3 – volume: 6 start-page: 580 issue: 11 year: 2014 ident: 1210_CR9 publication-title: N Am J Med Sci doi: 10.4103/1947-2714.145477 – volume: 29 start-page: 145 issue: 3 year: 2018 ident: 1210_CR7 publication-title: Urol Sci doi: 10.4103/UROS.UROS_20_17 – volume: 93 start-page: 291 issue: 3 year: 2018 ident: 1210_CR59 publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2017.11.018 – volume: 91 start-page: 1744 issue: 12 year: 2016 ident: 1210_CR48 publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2016.08.014 – volume: 95 start-page: 1810 issue: 4 year: 2010 ident: 1210_CR42 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-1796 – volume: 61 start-page: 923 issue: 6 year: 2013 ident: 1210_CR44 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2012.12.028 – volume: 199 start-page: 1534 issue: 6 year: 2018 ident: 1210_CR53 publication-title: J Urol doi: 10.1016/j.juro.2018.01.077 – start-page: 107 volume-title: Urolithiasis: basic science and clinical practice year: 2012 ident: 1210_CR24 doi: 10.1007/978-1-4471-4387-1_14 – volume: 10 start-page: S376 issue: Suppl 14 year: 1999 ident: 1210_CR38 publication-title: J Am Soc Nephrol – volume: 197 start-page: 405 issue: 2 year: 2017 ident: 1210_CR55 publication-title: J Urol doi: 10.1016/j.juro.2016.08.084 – volume: 3 start-page: 278 issue: 3 year: 2014 ident: 1210_CR1 publication-title: Transl Androl Urol doi: 10.3978/j.issn.2223-4683.2014.07.02 – volume: 45 start-page: 535 issue: 6 year: 2017 ident: 1210_CR54 publication-title: Urolithiasis doi: 10.1007/s00240-016-0954-x – volume: 313 start-page: 1973 issue: 19 year: 2015 ident: 1210_CR35 publication-title: JAMA doi: 10.1001/jama.2015.4260 – volume: 22 start-page: 113 issue: 2 year: 1990 ident: 1210_CR51 publication-title: Int Urol Nephrol doi: 10.1007/BF02549826 – volume: 12 start-page: e86 issue: 2–3 year: 2010 ident: 1210_CR12 publication-title: Rev Urol – volume: 6 start-page: 2069 issue: 8 year: 2011 ident: 1210_CR2 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.10651110 – volume: 293 start-page: 455 issue: 4 year: 2005 ident: 1210_CR29 publication-title: JAMA doi: 10.1001/jama.293.4.455 – volume: 27 start-page: 275 issue: 2 year: 2000 ident: 1210_CR27 publication-title: Urol Clin North Am doi: 10.1016/S0094-0143(05)70257-3 – volume: 319 start-page: 1723 issue: 16 year: 2018 ident: 1210_CR19 publication-title: JAMA doi: 10.1001/jama.2018.3060 – volume: 46 start-page: 543 issue: 6 year: 2018 ident: 1210_CR3 publication-title: Urolithiasis doi: 10.1007/s00240-018-1050-1 – volume: 9 start-page: 506 issue: 3 year: 2014 ident: 1210_CR8 publication-title: Clin J Am Soc Nephrol doi: 10.2215/cjn.04960513 – year: 2018 ident: 1210_CR10 publication-title: J Clin Urol doi: 10.1177/2051415818813820 – volume: 18 start-page: 654 issue: 2 year: 2007 ident: 1210_CR23 publication-title: J Am Soc Nephrol doi: 10.1681/asn.2006080854 – volume: 8 start-page: 901 issue: 6 year: 2013 ident: 1210_CR32 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.07190712 – volume: 10 start-page: 667 issue: 4 year: 2015 ident: 1210_CR56 publication-title: Clin J Am Soc Nephrol doi: 10.2215/cjn.07060714 – volume: 14 start-page: 347 issue: 5 year: 1977 ident: 1210_CR52 publication-title: Invest Urol – volume: 62 start-page: 160 issue: 1 year: 2012 ident: 1210_CR17 publication-title: Eur Urol doi: 10.1016/j.eururo.2012.03.052 – volume: 44 start-page: 409 issue: 5 year: 2016 ident: 1210_CR40 publication-title: Urolithiasis doi: 10.1007/s00240-016-0888-3 – ident: 1210_CR13 – volume: 68 start-page: 1230 issue: 3 year: 2005 ident: 1210_CR28 publication-title: Kidney Int doi: 10.1111/j.1523-1755.2005.00516.x – volume: 63 start-page: 1817 issue: 5 year: 2003 ident: 1210_CR15 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00917.x – volume: 44 start-page: 981 issue: 12 year: 2006 ident: 1210_CR37 publication-title: Indian J Exp Biol – volume: 168 start-page: 1923 issue: 5 year: 2002 ident: 1210_CR45 publication-title: J Urol doi: 10.1097/01.ju.0000033907.21910.be – volume: 141 start-page: 731 issue: 3 Pt 2 year: 1989 ident: 1210_CR25 publication-title: J Urol doi: 10.1016/S0022-5347(17)40997-9 – volume: 63 start-page: 255 issue: 1 year: 2003 ident: 1210_CR26 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00725.x – volume: 27 start-page: 309 issue: 2 year: 2019 ident: 1210_CR20 publication-title: Obesity doi: 10.1002/oby.22370 – volume: 59 start-page: 2290 issue: 6 year: 2001 ident: 1210_CR30 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2001.00746.x – volume: 18 start-page: 2198 issue: 7 year: 2007 ident: 1210_CR31 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007020219 – volume: 8 start-page: e75513 issue: 9 year: 2013 ident: 1210_CR46 publication-title: PLoS ONE doi: 10.1371/journal.pone.0075513 – volume: 71 start-page: 991 issue: 6 year: 2019 ident: 1210_CR21 publication-title: Arthr Rheumatol doi: 10.1002/art.40807 – volume: 66 start-page: 724 issue: 4 year: 2014 ident: 1210_CR16 publication-title: Eur Urol doi: 10.1016/j.eururo.2014.06.036 – volume: 16 start-page: S12 year: 2012 ident: 1210_CR43 publication-title: Indian J Endocrinol Metab doi: 10.4103/2230-8210.94248 – volume: 7 start-page: 1409 issue: 9 year: 2012 ident: 1210_CR5 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03210312 – volume: 96 start-page: 1911 issue: 7 year: 2011 ident: 1210_CR14 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-0385 – volume: 20 start-page: 6 issue: 1 year: 2017 ident: 1210_CR34 publication-title: Popul Health Manag doi: 10.1089/pop.2015.0181 – volume: 34 start-page: 1669 issue: 7 year: 2011 ident: 1210_CR41 publication-title: Diabetes Care doi: 10.2337/dc10-2339 – volume: 2018 start-page: 3068365 year: 2018 ident: 1210_CR11 publication-title: Adv Urol doi: 10.1155/2018/3068365 – volume: 87 start-page: 83 issue: 1 year: 2015 ident: 1210_CR39 publication-title: Arch Ital Urol Androl doi: 10.4081/aiua.2015.1.83 – volume: 7 start-page: 3 issue: 1 year: 2011 ident: 1210_CR47 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2010.206 – volume: 166 start-page: 1078 issue: 3 year: 2001 ident: 1210_CR36 publication-title: J Urol doi: 10.1016/S0022-5347(05)65925-3 – volume: 48 start-page: 305 issue: 4 year: 2020 ident: 1210_CR60 publication-title: Urolithiasis doi: 10.1007/s00240-019-01151-z – reference: 37965514 - Front Public Health. 2023 Oct 27;11:1203640 – reference: 34111940 - J Urol. 2021 Sep;206(3):765-767 |
| SSID | ssj0000999410 |
| Score | 2.6225803 |
| Snippet | The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported.... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 27 |
| SubjectTerms | Adult Aged Aged, 80 and over Creatinine Cross-Sectional Studies Diabetes Estrogens Ethnicity Female Hispanic people Humans Kidney Calculi - epidemiology Kidney diseases Kidney stones Male Medical Biochemistry Medicine Medicine & Public Health Middle Aged Nephrology Nutrition Nutrition Surveys - statistics & numerical data Nutrition Surveys - trends Original Paper Prevalence Self Report - statistics & numerical data Trace elements Trends United States - epidemiology Urine Urology Vitamin D Womens health Young Adult |
| SummonAdditionalLinks | – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50FfHi-1FdJYI3DbRJ2yRHERcvLosvvJWmbWBRurK7uvjvnaQPER-gpx4ybcNkJvMl8wI4lrbqm4lSKrNQ0bDwFdUp41TFURooHSgTZa7ZhOj35cODGtRJYZMm2r1xSbqduk12c-W4qD3u2DpkPp3NwwKaO2kbNlzf3Lc3KxbzhK4MAWpjSAVjss6W-f4zny3SF5j5xUXqLE9v9X9zXoOVGmmSs0o01mGuKDdg6ar2pW_CoAqHJcOSIAgkz2Nb-NvqORkZ8jjMy-KNWGRYtCQVPiUVPiU2MYXYO0gyHeEziLfgrndxe35J6_4KNOMimlLDtUJbxbSItBIaD8OpQfsfZyHL8eCQ60gxX-pQaYMjghncF00c5ULlnKW-4tvQKXEau0DiXGikD1SBkCSXcVow47NMaJ-jEASZB0HD4ySri4_bHhhPSVs22bEqQVYljlXJzIOT9p3nqvTGr9TdZumSWg0nCQtlLCVilMCDo3YYFch6RdKyGL1YGo6bUIAy68FOteTt77h1A3MpPDht1vfj4z_PZe9v5PuwzGykjIsF70JnOn4pDmAxe50OJ-NDJ9zvj_ruHQ priority: 102 providerName: Springer Nature |
| Title | Trends in the prevalence of kidney stones in the United States from 2007 to 2016 |
| URI | https://link.springer.com/article/10.1007/s00240-020-01210-w https://www.ncbi.nlm.nih.gov/pubmed/32870387 https://www.proquest.com/docview/2486884151 https://www.proquest.com/docview/2439631381 |
| Volume | 49 |
| WOSCitedRecordID | wos000565121400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: Springer Journals customDbUrl: eissn: 2194-7236 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000999410 issn: 2194-7228 databaseCode: RSV dateStart: 20130101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7SpJRe2vSRxm0SFOitFbUl25JOpQ0JuXRZ8ih7M5ZswdLi3exuEvrvOyNrHUpoLrnYGI_twTOSPs1I3wB81MT65ouaa5cbnrep4bYWkpuyqDNjM-MLF4pNqNFITyZmHANuy7isct0nho66mTmKkX8RuS61xuEm-zq_4lQ1irKrsYTGE9iistnk52qihhgLoZ88EBJgu8y5EkLHfTNh91zg9-I0fyJis5Tf_js23QOc95KlYQw6eflY7bfhRUSf7FvvLq9go-1ew7MfMb_-Bsb9Elk27RgCQzZfEBk4tX028-zXtOnaP4zQYjuI9JiV9ZiV0WYVRnFJtprhOSvfwuXJ8cXRKY81F7iTqlhxL63B8UtYVVijLE6Qa4-YoHS5aHAy0djCiFTb3FiPd5Tw2Ff6smiUaaSoUyN3YLNDNXaBlY2yKJ-ZFmFKo8u6FT4VTtlUomNkLoFs_bcrFwnJqS7G72qgUg4WqtBCVbBQdZvAp-GZeU_H8aD03toaVWyay-rOFAkcDrexUVGmpO7a2TXJSOyYMvTjBN71xh8-Jyk1LLVK4PPaG-5e_n9d3j-sywd4Lmi1TFgPvgebq8V1uw9P3c1qulwcBLcOR30AW9-PR-MzvDo7__kXNkT7Rw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VLYJeeD9SChgJTmA1cR62DwghoGrVdtVDkfYWYseWVqDsdnfbVf9UfyMzzqNCFb31wCkHO4kTjz9_Y4-_AXinSPXN5xVXNtM8c7HmphIp10VeJdok2uc2JJuQo5Eaj_XxGlz2Z2EorLLHxADU9dTSGvmOyFShFE43yefZKaesUbS72qfQaM3iwF2s0GVbfNr_hv37Xojd7ydf93iXVYDbVOZL7lOjEaGFkbnR0qALWHmc9QqbiRrpcm1yLWJlMm08lkjhEQ18kddS16mogvgSQv4G4rgkZ0-O5bCmQ2wrCwIIiAMZl0Ko7pxOOK0X9MQ4-WskpBbz1d9z4TWCe21zNsx5uw_-t7_1EO537Jp9aYfDI1hzzWO4e9TFDzyB4zYEmE0ahsSXzeYkdk7Yxqae_ZrUjbtgxIbdUKXl5Kzl5IwO4zBad2XLKV6T4in8uJXveQbrDTbjBbCilgbrJ9ohDatVUTnhY2GliVM0_MRGkPS9W9pOcJ3yfvwuB6noYBElWkQZLKJcRfBhuGfWyo3cWHu77_2yg55FedX1EbwdihE0aCeoatz0jOqkCLwJjtMInrfGNrwupa3vVMkIPvbWd_Xwf7dl6-a2vIF7eydHh-Xh_ujgJWwKigwKse_bsL6cn7lXcMeeLyeL-eswpBj8vG2r_ANwHlMH |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL2qpqhiw5sSKGAkWIHVxHnYXiAEtCOqwmiEQOouxI4tjUCZYWbKqL_G13Gv86hQRXddsMoiTuIkx8fH9vW5AM8Vub75vOLKZppnLtbcVCLlusirRJtE-9yGZBNyMlEnJ3q6Bb_7vTAUVtlzYiDqem5pjnxfZKpQCrubZN93YRHTg_GbxU9OGaRopbVPp9FC5NidbXD4tnp9dID_-oUQ48Mv7z_wLsMAt6nM19ynRiNbCyNzo6XB4WDlsQcsbCZqlM61ybWIlcm08XhGCo_M4Iu8lrpORRWMmJD-tyWKjGwE2-8OJ9PPwwwPaa8s2CEgK2RcCqG6XTth715wF-M0eiNbtZhv_u4ZL8jdC0u1oQcc3_yfv90tuNHpbva2bSi3Ycs1d2DnUxdZcBembXAwmzUMJTFbLMkGnViPzT37Pqsbd8ZIJ7uhSKvWWavWGW3TYTQjy9ZzPCbFPfh6Je9zH0YNVuMBsKKWBssn2qFAq1VROeFjYaWJU2wSiY0g6f90aTsrdsoI8qMcTKQDOkpERxnQUW4ieDlcs2iNSC4tvdcjoexIaVWewyCCZ8NppBNaI6oaNz-lMilScoItOILdFnjD41JaFE-VjOBVj8Tzm_-7Lg8vr8tT2EEwlh-PJseP4LqgkKEQFL8Ho_Xy1D2Ga_bXerZaPunaF4NvVw3LP1yNXSc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+the+prevalence+of+kidney+stones+in+the+United+States+from+2007+to+2016&rft.jtitle=Urolithiasis&rft.au=Chewcharat%2C+Api&rft.au=Curhan%2C+Gary&rft.date=2021-02-01&rft.eissn=2194-7236&rft.volume=49&rft.issue=1&rft.spage=27&rft_id=info:doi/10.1007%2Fs00240-020-01210-w&rft_id=info%3Apmid%2F32870387&rft.externalDocID=32870387 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2194-7228&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2194-7228&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2194-7228&client=summon |